Nanosuspension Formulations for Low-Soluble Drugs: Pharmacokinetic Evaluation Using Spironolactone as Model Compound

Author: Langguth P.   Hanafy A.   Frenzel D.   Grenier P.   Nhamias A.   Ohlig T.   Vergnault G.   Spahn-Langguth H.  

Publisher: Informa Healthcare

ISSN: 0363-9045

Source: Drug Development and Industrial Pharmacy, Vol.31, Iss.3, 2005-03, pp. : 319-329

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract